Hims & Hers (HIMS) missed Q1 2026 on revenue ($608.1M vs. consensus $616.85M) and earnings (-$0.40 EPS vs. expected $0.03), prompting Bank of America to cut its price target to $30 from $32 while ...

) has been revised to $25.63 / share. This is a decrease of 14.58% from the prior estimate of $30.00 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...

Hims & Hers has been one of the most closely watched names in digital health this month. Between the FDA's peptide announcement, a Novo Nordisk settlement, and a flood of analyst revisions, the stock ...

Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer telehealth name following a messy first quarter. The firm lowered its price target ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Echoing this, Hims & Hers Health stock sports a Schaeffer's put/call open interest ratio (SOIR) of 0.61. This ratio ranks ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Hims & Hers Health (NYSE:HIMS) absorbed another analyst downgrade. Bank of America cut its price objective on Hims & Hers stock to $30 from $32, while keeping a Neutral rating. The firm called the ...